Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

Julie Andrews, the Chief Financial Officer of Orthofix Medical (TASE:PMCN) Inc. (NASDAQ:OFIX), recently sold a portion of her holdings in the company. According to a recent filing, Andrews sold 4,655 ...

If you’ve ever had a particularly nasty fracture, your doctor may have prescribed the use of an electronic bone growth stimulator. These wearable devices produce a pulsed electromagnetic field ...

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period. The most recent guidance for Orthofix ...

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment ...

AtriCure has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more ...

GET MORE AI-GENERATED SIGNALS: January 16, 2025, 22:48 pm ET, BY Bill T.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy recommendation. As of December 23, 2024, the average one-year price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...